Citations

Showing 10 of 108094 citations.

A National Contemporary Analysis of Perioperative Outcomes of Open versus Minimally Invasive Sacrocolpopexy
Linder, Brian J. , Occhino, John A. , Habermann, Elizabeth B. , Glasgow, Amy E. , Bews, Katherine A. , Gershman, Boris , Glasgow, Amy E. , Habermann, Elizabeth , Glasgow, Amy E , Linder, Brian J

Mayo Clinic

Journal of Urology | April 7, 2018 | Volume: 200 | Issue: 4 | Pages: 862-867

10.1016/j.juro.2018.03.131 | PMID 29630983 Get It

Eight Years of Clinical Legionella PCR Testing Illustrates a Seasonal Pattern
Rucinski, Stefanea L., Kies, Kami D, Cunningham, Scott A. , Patel, Robin , Murphy, Matthew P., Patel, Robin , Murphy, Matthew Philip , Schuetz, Audrey N. , Cunningham, Scott A

Mayo Clinic

The Journal of Infectious Diseases | April 7, 2018 | Volume: 218 | Issue: 4 | Pages: 669-670

10.1093/infdis/jiy201 | PMID 29659880 Get It

AutoVOI: real‐time automatic prescription of volume‐of‐interest for single voxel spectroscopy
Park, Young Woo , Deelchand, Dinesh K. , Joers, James M. , Hanna, Brian, Berrington, Adam , Gillen, Joseph , Kantarci, Kejal , Soher, Brian J. , Barker, Peter B. , Park, HyunWook , Öz, Gülin , Lenglet, Christophe , Öz, Gülin , Kantarci, Kejal , Deelchand, Dinesh K

Mayo Clinic

Magnetic Resonance in Medicine | April 6, 2018 | Volume: 80 | Issue: 5 | Pages: 1787-1798

10.1002/mrm.27203 | PMID 29624727 Get It

PurposeTo develop a fast and automated volume‐of‐interest (VOI) prescription pipeline (AutoVOI) for single‐voxel MRS that removes the need for manual VOI placement, allows flexible VOI planning in any brain region, and enables high inter‐ and intra‐subject consistency of VOI prescription.MethodsAutoVOI was designed to transfer pre‐defined VOIs from an atlas to the 3D anatomical data of the subject during the scan. The AutoVOI pipeline was optimized for consistency in VOI placement (precision), enhanced coverage of the targeted tissue (accuracy), and fast computation speed. The tool was evaluated against manual VOI placement using existing T1‐weighted data sets and corresponding VOI prescriptions. Finally, it was implemented on 2 scanner platforms to acquire MRS data from clinically relevant VOIs that span the cerebrum, cerebellum, and the brainstem.ResultsThe AutoVOI pipeline includes skull stripping, non‐linear registration of the atlas to the subject's brain, and computation of the VOI coordinates and angulations using a minimum oriented bounding box algorithm. When compared against manual prescription, AutoVOI showed higher intra‐ and inter‐subject spatial consistency, as quantified by generalized Dice coefficients (GDC), lower intra‐ and inter‐subject variability in tissue composition (gray matter, white matter, and cerebrospinal fluid) and higher or equal accuracy, as quantified by GDC of prescribed VOI with targeted tissues. High quality spectra were obtained on Siemens and Philips 3T systems from 6 automatically prescribed VOIs by the tool.ConclusionRobust automatic VOI prescription is feasible and can help facilitate clinical adoption of MRS by avoiding operator dependence of manual selection.
Increased Chromogranin A–Positive Hormone-Negative Cells in Chronic Pancreatitis
Moin, Abu Saleh Md , Cory, Megan , Choi, Jennifer, Ong, Allison, Dhawan, Sangeeta , Butler, Peter C. , Rizza, Robert A., Butler, Alexandra E. , Ong, Allison, Dhawan, Sangeeta , Dry, Sarah

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | April 6, 2018 | Volume: 103 | Issue: 6 | Pages: 2126-2135

10.1210/jc.2017-01562 | PMID 29659906 Get It

AbstractContextChronic pancreatitis (CP) is characterized by inflammation, fibrosis, and a loss of pancreatic acinar cells, which can result in exocrine and eventually endocrine deficiency. Pancreatitis has been reported to induce formation of new endocrine cells (neogenesis) in mice. Our recent data have implicated chromogranin A–positive hormone-negative (CPHN) cells as potential evidence of neogenesis in humans.ObjectiveWe sought to establish if CPHN cells were more abundant in CP in humans.Design, Setting, and ParticipantsWe investigated the frequency and distribution of CPHN cells and the expression of the chemokine C-X-C motif ligand 10 (CXCL10) and its receptor chemokine C-X-C motif receptor 3 in pancreas of nondiabetic subjects with CP.ResultsCPHN cell frequency in islets was increased sevenfold in CP [2.1% ± 0.67% vs 0.35% ± 0.09% CPHN cells in islets, CP vs nonpancreatitis (NP), P < 0.01], as were the CPHN cells found as scattered cells in the exocrine areas (17.4 ± 2.9 vs 4.2 ± 0.6, CP vs NP, P < 0.001). Polyhormonal endocrine cells were also increased in CP (2.7 ± 1.2 vs 0.1 ± 0.04, CP vs NP, % of polyhormonal cells of total endocrine cells, P < 0.01), as was expression of CXCL10 in α and β cells.ConclusionThere is increased islet endogenous expression of the inflammation marker CXCL10 in islets in the setting of nondiabetic CP and an increase in polyhormonal (insulin-glucagon expressing) cells. The increase in CPHN cells in CP, often in a lobular distribution, may indicate foci of attempted endocrine cell regeneration.
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Marrero, Jorge A. , Kulik, Laura , Zhu, Andrew X. , Roberts, Lewis R. , Roberts, Lewis R , Sirlin, Claude B. , Finn, Richard S. , Abecassis, Michael M. , Heimbach, Julie K.

Mayo Clinic

Hepatology | April 6, 2018 | Volume: 68 | Issue: 2 | Pages: 723-750

10.1002/hep.29913 | PMID 29624699 Get It

Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice
Chiang, Angie C.A. , Fowler, Stephanie , Savjani, Ricky R. , Hilsenbeck, Susan G. , Wallace, Clare E. , Cirrito, John R. , Das, Pritam , Jankowsky, Joanna L. , Savjani, Ricky R. , Hilsenbeck, Susan Galloway

Mayo Clinic

Journal of Experimental Medicine | April 6, 2018 | Volume: 215 | Issue: 5 | Pages: 1349-1364

10.1084/jem.20171484 | PMID 29626114 Get It

Drug development for Alzheimer’s disease has endeavored to lower amyloid β (Aβ) by either blocking production or promoting clearance. The benefit of combining these approaches has been examined in mouse models and shown to improve pathological measures of disease over single treatment; however, the impact on cellular and cognitive functions affected by Aβ has not been tested. We used a controllable APP transgenic mouse model to test whether combining genetic suppression of Aβ production with passive anti-Aβ immunization improved functional outcomes over either treatment alone. Compared with behavior before treatment, arresting further Aβ production (but not passive immunization) was sufficient to stop further decline in spatial learning, working memory, and associative memory, whereas combination treatment reversed each of these impairments. Cognitive improvement coincided with resolution of neuritic dystrophy, restoration of synaptic density surrounding deposits, and reduction of hyperactive mammalian target of rapamycin signaling. Computational modeling corroborated by in vivo microdialysis pointed to the reduction of soluble/exchangeable Aβ as the primary driver of cognitive recovery.
Relationship between Hospital 30‐Day Mortality Rates for Heart Failure and Patterns of Early Inpatient Comfort Care
Chen, Lena M. , Levine, Deborah A. , Hayward, Rodney A. , Cox, Margueritte, Schulte, Phillip J. , Heidenreich, Paul A. , DeVore, Adam D. , Hernandez, Adrian F. , Yancy, Clyde W. , Fonarow, Gregg C.

Mayo Clinic

Journal of Hospital Medicine | April 6, 2018 | Volume: 13 | Issue: 3 | Pages: 170-176

10.12788/jhm.2862 | PMID 29505624 Get It

BACKGROUNDThe Centers for Medicare & Medicaid Services rewards hospitals that have low 30‐day risk‐standardized mortality rates (RSMR) for heart failure (HF).OBJECTIVETo describe the use of early comfort care for patients with HF, and whether hospitals that more commonly initiate comfort care have higher 30‐day mortality rates.DESIGNA retrospective, observational study.SETTINGAcute care hospitals in the United States.PATIENTSA total of 93,920 fee‐for‐service Medicare beneficiaries admitted with HF from January 2008 to December 2014 to 272 hospitals participating in the Get With The Guidelines‐Heart Failure registry.EXPOSUREEarly comfort care (defined as comfort care within 48 hours of hospitalization) rate.MEASUREMENTSA 30‐day RSMR.RESULTSHospitals' early comfort care rates were low for patients admitted for H F, with no change over time (2.5% to 2.6%, from 2008 to 2014, P = .56). Rates varied widely (0% to 40%), with 14.3% of hospitals not initiating comfort care for any patients during the first 2 days of hospitalization. Risk‐standardized early comfort care rates were not correlated with RSMR (median RSMR = 10.9%, 25th to 75th percentile = 10.1% to 12.0%; Spearman's rank correlation = 0.13; P = .66).CONCLUSIONSHospital use of early comfort care for HF varies, has not increased over time, and on average, is not correlated with 30‐day RSMR. This suggests that current efforts to lower mortality rates have not had unintended consequences for hospitals that institute early comfort care more commonly than their peers.
Ginseng as a Treatment for Fatigue: A Systematic Review
Arring, Noël , Millstine, Denise , Marks, Lisa , Nail, Lillian M., Arring, Noël M, Marks, Lisa A., Marks, Lisa A

Mayo Clinic

The Journal of Alternative and Complementary Medicine | April 6, 2018 | Volume: 24 | Issue: 7 | Pages: 624-633

10.1089/acm.2017.0361 | PMID 29624410 Get It

Endotracheal Intubation in Critically III Patients: Direct Laryngoscopy, Complications, and Cardiac Arrest
Nasim, Faria, Chae, June, Goel, Sangita, Ramar, Kannan, Ramar, Kannan

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 6, 2018 | Volume: 197 | Issue: 12 | Pages: 1625-1627

10.1164/rccm.201709-1884rr | PMID 29624406 Get It